WMSA
TELA icon

Weiss Multi-Strategy Advisers’s TELA Bio TELA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22,000
Closed -$285K – 677
2020
Q2 		$285K Buy
+22,000
New +$289K 0.01% 498

Other funds holding TELA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TELA Position: Q3 2020 in Review

Weiss Multi-Strategy Advisers sold out of TELA Bio (TELA) in Q3 2020, closing a stake of 22,000 shares — an estimated $285K sold.

Weiss Multi-Strategy Advisers first reported a position in TELA in Q2 2020 and held it in 1 quarter. The position peaked at $285K in Q2 2020. 44 funds tracked by Wall St. Rank hold TELA as of Q3 2020.

  • Weiss Multi-Strategy Advisers reported no remaining TELA Bio position as of Q3 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 22,000 TELA Bio shares in Q3 2020, an estimated $285K.
  • Weiss Multi-Strategy Advisers first reported a position in TELA Bio in Q2 2020 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's TELA Bio position peaked at $285K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held TELA Bio as of Q3 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.